Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.dsx.2020.07.054 http://scihub22266oqcxt.onion/10.1016/j.dsx.2020.07.054 32771919!7395301!32771919     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Diabetes+Metab+Syndr 2020 ; 14 (5): 1463-1465 Nephropedia Template TP {{tp|p=32771919|t=2020. Dyslipidemia is associated with severe coronavirus disease 2019 (COVID-19) infection |pdf=|usr=}}{{32771919}} gab.com Text Dyslipidemia is associated with severe coronavirus disease 2019 (COVID-19) infection JO: Diabetes Metab Syndr http://www.kidney.de/pget.php?&tw=1&pmid=32771919 #FOAvip BACKGROUND AND AIMS: The number of positive and death cases from coronavirus disease 2019 (COVID-19) is still increasing. The identification of risk factors for severe outcomes is important. Dyslipidemia has been shown as a long-known risk factor for cardiovascular disease. The aim of this study is to analyze the potential association between dyslipidemia and the severity of COVID-19 infection. METHODS: We systematically searched the PubMed database using specific keywords related to our aims until July 9th, 2020. All articles published on COVID-19 and dyslipidemia were retrieved. Statistical analysis was done using Review Manager 5.4 software. RESULTS: A total of 7 studies with a total of 6922 patients were included in our analysis. Our meta-analysis showed that dyslipidemia is associated with severe COVID-19 infections [RR 1.39 (95% CI 1.03-1.87), p = 0.03, I(2) = 57%, random-effect modelling]. CONCLUSION: Dyslipidemia increases the risk of the development of severe outcomes from COVID-19 infections. Patients with dyslipidemia should be monitored closely to minimize the risk of COVID-19. Twit Text FOAVip Dyslipidemia is associated with severe coronavirus disease 2019 (COVID-19) infection ????Diabetes Metab Syndr http://www.kidney.de/pget.php?&tw=1&pmid=32771919 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32771919 #FOAvip English Wikipedia <ref>{{Cite pmid|32771919}}</ref> Dyslipidemia is associated with severe coronavirus disease 2019 (COVID-19) infection #MMPMID32771919 Hariyanto TI; Kurniawan A Diabetes Metab Syndr 2020[Sep]; 14 (5): 1463-1465 PMID32771919show ga BACKGROUND AND AIMS: The number of positive and death cases from coronavirus disease 2019 (COVID-19) is still increasing. The identification of risk factors for severe outcomes is important. Dyslipidemia has been shown as a long-known risk factor for cardiovascular disease. The aim of this study is to analyze the potential association between dyslipidemia and the severity of COVID-19 infection. METHODS: We systematically searched the PubMed database using specific keywords related to our aims until July 9th, 2020. All articles published on COVID-19 and dyslipidemia were retrieved. Statistical analysis was done using Review Manager 5.4 software. RESULTS: A total of 7 studies with a total of 6922 patients were included in our analysis. Our meta-analysis showed that dyslipidemia is associated with severe COVID-19 infections [RR 1.39 (95% CI 1.03-1.87), p = 0.03, I(2) = 57%, random-effect modelling]. CONCLUSION: Dyslipidemia increases the risk of the development of severe outcomes from COVID-19 infections. Patients with dyslipidemia should be monitored closely to minimize the risk of COVID-19. |Betacoronavirus[MESH] |COVID-19[MESH] |Coronavirus Infections/*complications[MESH] |Dyslipidemias/*complications[MESH] |Humans[MESH] |Pandemics[MESH] |Pneumonia, Viral/*complications[MESH]Dyslipidemia is associated with severe coronavirus disease 2019 (COVID(epmc).pdf DeepDyve Pubget Overpricing